JD HEALTH
06618
NTES-S
09999
ALI HEALTH
00241
4
BEKE-W
02423
5
BILIBILI-W
09626
(FY)Dec 31, 2024 | (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | (Q3)Mar 31, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Turnover | 4.66%80.73M | 12.26%42.77M | -10.45%77.13M | -8.14%57.94M | -9.82%38.1M | -13.40%20M | -12.79%86.13M | -17.00%63.08M | -17.47%42.25M | -10.66%23.09M |
Operating income | 4.66%80.73M | 12.26%42.77M | -10.45%77.13M | -8.14%57.94M | -9.82%38.1M | -13.40%20M | -12.79%86.13M | -17.00%63.08M | -17.47%42.25M | -10.66%23.09M |
Operating expenses | ||||||||||
Gross profit | ||||||||||
Employee expense | -19.06%-77.97M | -7.79%-35.36M | 6.37%-65.49M | 4.32%-49.34M | 5.72%-32.81M | 16.08%-16.65M | 4.83%-69.95M | 6.65%-51.57M | 4.77%-34.8M | -7.21%-19.84M |
Depreciation and amortization | -59.25%-3.34M | 31.73%-839K | 44.69%-2.1M | 64.10%-1.76M | 62.87%-1.23M | 61.61%-645K | 59.40%-3.79M | 36.47%-4.91M | 36.69%-3.31M | 38.14%-1.68M |
Special items of operating profit | 226.41%10.04M | -1,055.65%-3.56M | 61.03%-7.94M | 88.94%-427K | 117.58%372K | 121.55%531K | 38.59%-20.37M | 75.88%-3.86M | 78.54%-2.12M | 31.88%-2.46M |
Operating profit | 487.99%9.45M | -32.04%3.01M | 120.14%1.61M | 133.82%6.42M | 119.12%4.44M | 460.49%3.23M | 53.74%-7.98M | 192.30%2.74M | 558.96%2.02M | -189.33%-896K |
Financing cost | 72.75%-185K | 60.00%-12K | 37.88%-679K | -314.75%-506K | 74.36%-30K | 40.43%-28K | -120.36%-1.09M | -1.67%-122K | -4.46%-117K | -20.51%-47K |
Earning before tax | 898.28%9.26M | -31.85%3M | 110.23%928K | 125.40%5.91M | 130.99%4.41M | 439.55%3.2M | 48.88%-9.07M | 184.77%2.62M | 444.85%1.91M | -197.82%-943K |
Tax | -552.67%-855K | 28.34%-177K | 41.26%-131K | 57.36%-287K | 49.39%-247K | 33.60%-168K | 74.43%-223K | 38.98%-673K | 35.79%-488K | 33.77%-253K |
After-tax profit from continuing operations | 955.08%8.41M | -32.06%2.83M | 108.57%797K | 188.51%5.62M | 193.02%4.16M | 353.68%3.03M | 50.08%-9.3M | 146.45%1.95M | 208.07%1.42M | -305.50%-1.2M |
After-tax profit from non-continuing business | 204.37%9.1M | ---- | ---8.72M | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Earning after tax | 321.02%17.51M | -32.06%2.83M | 14.78%-7.92M | 188.51%5.62M | 193.02%4.16M | 353.68%3.03M | 50.08%-9.3M | 146.45%1.95M | 208.07%1.42M | -305.50%-1.2M |
Profit attributable to shareholders | 321.02%17.51M | -32.06%2.83M | 14.78%-7.92M | 188.51%5.62M | 193.02%4.16M | 353.68%3.03M | 50.08%-9.3M | 146.45%1.95M | 208.07%1.42M | -305.50%-1.2M |
Basic earnings per share | 310.71%0.059 | -35.57%0.0096 | 15.15%-0.028 | 171.43%0.019 | 192.16%0.0149 | 351.16%0.0108 | 50.75%-0.033 | 146.67%0.007 | 208.51%0.0051 | -304.76%-0.0043 |
Diluted earnings per share | 310.71%0.059 | -35.57%0.0096 | 15.15%-0.028 | 171.43%0.019 | 192.16%0.0149 | 351.16%0.0108 | 50.75%-0.033 | 146.67%0.007 | 208.51%0.0051 | -304.76%-0.0043 |
Currency Unit | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD |
Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
Audit Opinions | -- | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion | -- | -- | -- |
Auditor | -- | -- | Guowei Certified Public Accountants Co., Ltd. | -- | -- | -- | Guowei Certified Public Accountants Co., Ltd. | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.